Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.45B
Enterprise Value2.9B
P/E Ratio-5.58
PEG Ratio0.08
Price/Sales Ratio3.44
Price/Book Ratio3.55
Enterprise/Revenue4.03
Enterprise/EBITDA-9.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.63
Operating Margin-0.69
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.5

Income Statement

Revenue623.97M
Revenue/Share1.84
Gross Profit165.8M
EBITDA-231.66M
Net Income-404.49M
Diluted EPS-1.16

Balance Sheet

Total Cash329.05M
Total Cash/Share0.95
Total Debt709.93M
Total Debt/Equity1.14
Current Ratio0.62
Book Value Per Share1.71

Price History

52-Week Change-6.31
52-Week High10.42
52-Week Low5
Moving Average 50 Days5.82
Moving Average 200 Days7.11

Statistics

Average Volume7.84M
Shares Outstanding344M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.1
Last Split Factor6:5
Last Split DateMay 29, 2020
AD